12:00 AM
Sep 20, 1999
 |  BC Week In Review  |  Clinical News  |  Clinical Status

SRL172: Completed Phase III trial enrollment

(Phase II data, B10)

SR Pharma plc (LSE:SPA), London, U.K.
Product: SRL172
Business: Cancer ...

Read the full 69 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >